Placeholder Banner

How Many Public Biotechs Remain?

December 3, 2009
The number of US public biotechs has dropped from almost 400 in January 2008 to a little over 300 in October 2009. About half of these are due to acquisitions, the other half are largely OTC companies that failed to file with the SEC, have filed bankruptcy or are in liquidation.